주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-19 17:10 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Pharma
목록
(
총 :
2,298 )
기사목록 보기 형태
제목형
요약형
포토형
Can Daewoong’s SLGT-2 inhibitor diabetes treatment be Korea’s 36th new drug?
Kim Chan-hyuk
2022.09.19 16:39
Takeda’s Zejula proves continuous progression-free survival as ovarian cancer therapy
Marianne Chang
2022.09.19 14:21
Yuhan’s takeover of AtoGen draws the industry’s attention
Kim Chan-hyuk
2022.09.16 13:32
Dx&Vx acquires Korea Bio Pharm for ₩15 billion for CDMO biz
Lee Han-soo
2022.09.16 11:11
Korean biopharma companies face cash crunch
Lee Han-soo
2022.09.15 16:52
Dong-A ST licenses out 2 drug candidates to NeuroBo Pharmaceuticals
Lee Han-soo
2022.09.15 15:48
Chinese regulator accepts Daehwa Pharm’s sales application for oral paclitaxel drug
Park Gi-taek
2022.09.15 15:29
Lilly rolls out RET targeted therapy Retevmo in Korea
Kim Yoon-mi
2022.09.15 13:44
Ministry adds ‘TLS’ to adverse effects of sorafenib drugs
Kim Chan-hyuk
2022.09.14 16:25
Qurient, MSD to co-research combination therapy for advanced solid cancer
Lee Han-soo
2022.09.14 16:03
MedPacto unveils Vactosertib combination study at AACR Special Conference on Pancreatic Cancer
Lee Han-soo
2022.09.14 11:22
Regulator suspends manufacturing of Samsung Pharm’s nutritional injections for 3 months
Kim Chan-hyuk
2022.09.13 13:11
처음
이전
이전
이전
111
112
113
114
115
116
117
118
119
120
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기